Abstract
ABSTRACT: Metabolism of propionate in human subjects was studied using bolus administration of 1-13C-propionate i.v. or orally. The study population consisted of five patients with propionic acidemia (PA), eight with methylmalonic acidemia (MMA; four responsive to vitamin B12), one each with multiple carboxylase deficiency and transcobalamin-II deficiency, and five healthy volunteers. Concentrations of 1-13C-propionate were measured in blood in three patients with PA, two with MMA, and two controls. Breath samples were obtained at intervals during 3 h after the dose, isotopic enrichment of 13CO2 was measured, and the cumulative percentage of recovery of 13C was calculated from the individual's predicted resting energy expenditure. Recovery of 13CO2 and half-time of 1-13C-propionate in PA were significantly less than normal. The same parameters in MMA were below normal, but significantly greater than in PA. Recovery of 13CO2 was well correlated with clinical severity in PA, but did not correlate in MMA. Differences between MMA and PA may indicate different distribution of propionate pools, differences in inducibility of residual enzyme activities, or an alternate pathway for decarboxylation of propionate available in MMA but not PA. Only one patient with PA demonstrated increased 13CO2 production during biotin treatment. In a B12-responsive MMA patient, no differences were noted within 2 d of initiating treatment with B12, but there was an increase in 13CO2 production after 4 mo. Recovery of 13CO2 was normal in the patient with transcobalamin-II deficiency before and after treatment with vitamin B12. In the patient with multiple carboxylase deficiency, 13CO2 generation was nearly normal while he was receiving his maintenance dose of biotin, and was not significantly changed after 3 and 7 d without biotin treatment, despite a decrease of 30% in lymphocyte propionyl-CoA carboxylase activity.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barshop, B., Yoshida, I., Ajami, A. et al. Metabolism of 1-13C-Propionate In Vivo in Patients with Disorders of Propionate Metabolism. Pediatr Res 30, 15–22 (1991). https://doi.org/10.1203/00006450-199107000-00004
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199107000-00004
This article is cited by
-
Intellectual disability and autism in propionic acidemia: a biomarker-behavioral investigation implicating dysregulated mitochondrial biology
Molecular Psychiatry (2024)
-
Gene therapy in a murine model of methylmalonic acidemia using rAAV9-mediated gene delivery
Gene Therapy (2012)
-
Long-term Rescue of a Lethal Murine Model of Methylmalonic Acidemia Using Adeno associated Viral Gene Therapy
Molecular Therapy (2010)
-
Late‐onset holocarboxylase synthetase deficiency
Journal of Inherited Metabolic Disease (1996)
-
The management and outcome of propionic and methylmalonic acidaemia
Journal of Inherited Metabolic Disease (1995)